Nexalin Technology, Inc.(NXL)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Nexalin Technology, Inc. (NXL) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores NXL at 20.1/100 on a 32-signal composite quality model, placing it at rank #2,782 of 2,960 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), Nexalin Technology, Inc. reports quarterly revenue of $12.2K, net income of $-2.2M. Top institutional holders of NXL by reported 13-F value include PEAK6, GEODE CAPITAL MANAGEMENT, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. NXL trades on the Nasdaq exchange and files with the SEC under CIK 1527352. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NXL daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Nexalin Technology, Inc. directly from SEC EDGAR.